gut microbiome

Highlights from AACR 2025, COVID-19 vaccine flip flops, an FDA approval for a rare skin disorder, and more led biotech and pharma news this week.

By using phages to deliver genes for therapeutic proteins, biologic drug delivery could become much easier.

Antibiotics target bacteria, but new work in mice shows they also harm the mucus layer that protects the intestinal lining from microbes.

Targeting a gut bacterial species or its metabolites could potentially improve diabetes management by reducing sugar preferences. 

Gut microbes can protect or sensitize each other to drugs, even to non-antibiotics.

From signaling hunger to influencing mood, the vagus nerve keeps the gut and brain in sync. 

Fiber found in bananas and garlic suppressed allergic reactions in mice.

A new metabolic model predicted short-chain fatty acid production based on an individual’s microbiome, diet, and prebiotic or probiotic input.

Researchers target the gut to see if they can treat depression with fewer side effects and less stigma than current drugs.

One of the most common bacterial infections, urinary tract infections, may have promising new therapeutics on the way.